Company Search:
Advanced Search
Sponsored Links
Immunomedics, Inc. Company Snapshot
Immunomedics, Inc. operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immunomedics with three other pharmaceutical manufacturers in North America: Oncobiologics Inc (2017 sales of $3.81 million ), Procyon Corporation ($4.01 million ), and MPX Bioceutical Corp which is based in Canada (4.38 million Canadian Dollars [US$3.52 million] ).

Sales Analysis. During the year ended June of 2017, sales at Immunomedics were $3.09 million. This is a decrease of 4.4% versus 2016, when the company's sales were $3.23 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Immunomedics, Inc.
  Stock Performance Chart for Immunomedics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 15.99
(Figures in U.S. Dollars)
1 Week -3.1%   13 Weeks 9.1%  
4 Weeks 45.4%   52 Weeks 269.3%  
Immunomedics, Inc. Key Data:
  Ticker: IMMU Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 3,091,250
(Year Ending Jan 2018).
Employees: 131
  Currency: U.S. Dollars Market Cap: 2,430,809,010
  Fiscal Yr Ends: June Shares Outstanding: 152,020,576
  Share Type: Common Closely Held Shares: 9,245,416
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.